Myomo Inc (NYSEAmerican:MYO) reported the inclusion of six new orthotics and prosthetics sites to its Center of Excellence program, which identifies leading O&P practices that boost the MyoPro line of supported orthoses. The company is currently the sole lightweight wearable device that can assist restore function in the weakened or paralyzed hands and arms of people who have suffered a brachial plexus injury, stroke or other neuromuscular disability.
The details
With the orthosis, a paralyzed person can perform many activities of daily living counting feeding themselves, doing household tasks and carrying objects, and many can return to work. The inclusions to the Center of Excellence program come upon the firm’s footprint as it intends a presence in all the leading metropolitan areas in the United States. These comprise three new firms, as well as three new sites of Geauga Rehabilitation Engineering, an original Myomo CoE. The new sites are Loma Linda University Medical Center, Orthocraft, Cunningham Prosthetic Care and GRE locations in Cincinnati, OH, Detroit, MI and Columbus, OH.
Paul R. Gudonis, the CEO and Chairman of Myomo, expressed that they introduced their Center of Excellence plan in attempt to better advance O&P practices who have demonstrated a commitment to patient care by offering the MyoPro device. Brining these new practices to their Center of Excellence roster merely four months after introducing the program allows them to serve a growing number of patients across the nation who may be able to gain from the MyoPro orthosis.
Myomo CoEs contribute in joint marketing initiatives and receive patient support and training from Myomo. They also associate with therapists and physicians at major U.S. rehabilitation hospitals, who prescribe and recommend MyoPro and train new MyoPro users. Vince Baroni, the Clinical Director for GRE, expressed that their robust association with Myomo has turned into remarkable patient outcomes.
